These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26255807)

  • 1. Oral antineoplastic agents: how do we care about adherence?
    Barillet M; Prevost V; Joly F; Clarisse B
    Br J Clin Pharmacol; 2015 Dec; 80(6):1289-302. PubMed ID: 26255807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on adherence management in patients on oral cancer therapies.
    Wood L
    Eur J Oncol Nurs; 2012 Sep; 16(4):432-8. PubMed ID: 22051845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
    Gebbia V; Bellavia G; Ferraù F; Valerio MR
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Adherence to Oral Antineoplastic Therapies.
    Greer JA; Amoyal N; Nisotel L; Fishbein JN; MacDonald J; Stagl J; Lennes I; Temel JS; Safren SA; Pirl WF
    Oncologist; 2016 Mar; 21(3):354-76. PubMed ID: 26921292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to oral antineoplastic agents by cancer patients: definition and literature review.
    Bassan F; Peter F; Houbre B; Brennstuhl MJ; Costantini M; Speyer E; Tarquinio C
    Eur J Cancer Care (Engl); 2014 Jan; 23(1):22-35. PubMed ID: 24079854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review.
    Verbrugghe M; Verhaeghe S; Lauwaert K; Beeckman D; Van Hecke A
    Cancer Treat Rev; 2013 Oct; 39(6):610-21. PubMed ID: 23428230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient adherence and persistence with oral anticancer treatment.
    Ruddy K; Mayer E; Partridge A
    CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
    Foulon V; Schöffski P; Wolter P
    Acta Clin Belg; 2011; 66(2):85-96. PubMed ID: 21630604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of adherence to oral therapies in the field of oncology: the example of breast cancer].
    Huiart L; Bardou VJ; Giorgi R
    Bull Cancer; 2013 Oct; 100(10):1007-15. PubMed ID: 24113516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees.
    Patel K; Sudhir VS; Kabadi S; Huang JC; Porwal S; Thakkar K; Pagel JM
    J Oncol Pharm Pract; 2019 Dec; 25(8):1897-1906. PubMed ID: 30823852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
    Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
    J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to targeted oral anticancer medications.
    Geynisman DM; Wickersham KE
    Discov Med; 2013 Apr; 15(83):231-41. PubMed ID: 23636140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
    Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
    BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review.
    Bergsbaken JJ; Eickhoff JC; Buss BA; Mably MS; Kolesar JM
    J Oncol Pharm Pract; 2016 Feb; 22(1):105-13. PubMed ID: 25577495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.
    Liewer S; Huddleston AN
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):453-64. PubMed ID: 25683755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to oral chemotherapy: Challenges and opportunities.
    Krikorian S; Pories S; Tataronis G; Caughey T; Chervinsky K; Lotz M; Shen AH; Weissmann L
    J Oncol Pharm Pract; 2019 Oct; 25(7):1590-1598. PubMed ID: 30253725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to oral cancer therapies: nursing interventions.
    Winkeljohn D
    Clin J Oncol Nurs; 2010 Aug; 14(4):461-6. PubMed ID: 20682501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review.
    Rosenberg SM; Petrie KJ; Stanton AL; Ngo L; Finnerty E; Partridge AH
    J Natl Cancer Inst; 2020 May; 112(5):443-465. PubMed ID: 31899790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.